One potential therapeutic strategy in the treatment of atherosclerosis or other cardiovascular diseases is the use of naphthalene-1-sulfonamide derivatives, which are selective FABP4 inhibitors [12,13]. This evidence concerns the gene FABP4 and atherosclerosis.